Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Saniona is a research and development company with low burn rate, a world class team and high ambitions.
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Akouos is a biotechnology company focusing on restoring and preserving hearing.
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Quench Bio is a developer of gasdermin biology drugs designed to treat severe inflammatory diseases.
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Crescent Pass Energy is an oil and gas company based in Houston, Texas.
Attune Pharmaceuticals is a private biotechnology company.
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .
CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.
Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.
We transform the management of OUD to help people begin and sustain recovery.
Adeo Health Science is consumer health and biotechnology company, focusing on improving immune health in infants
OvaScience is a life sciences company focused on the discovery, development and commercialization of treatments for infertility.
Antera Therapeutics is creating therapies that will prevent allergy development in children.
Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.
RA Capital Management has invested in 453 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Life Science. The firm invests across 15 different industry categories.
Among tracked funding rounds, Aurinia Pharmaceuticals received $200.0M in a Post Ipo Equity round. RA Capital Management's total known invested capital is $49.1B.
RA Capital Management's average investment size is $128.6M across its portfolio of 453 companies.
Recent RA Capital Management portfolio additions include AavantiBio, Saniona, Aerovate Therapeutics, PMV Pharmaceuticals, Aurinia Pharmaceuticals. These companies were founded in 2020 or later.